NanoSphere Health Sciences, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA63010P2098
CAD
0.03
-0.01 (-28.57%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About NanoSphere Health Sciences, Inc. stock-summary
stock-summary
NanoSphere Health Sciences, Inc.
Pharmaceuticals & Biotechnology
Nanosphere Health Sciences Inc (NanoSphere), formerly Corazon Gold Corp is Canada-based company engaged in medicinal and botanical manufacturing sector. The Company is commercializing its disruptive, nanoparticle delivery system platforms for cannabis under the brand Evolve Formulas available in a number of accounts throughout Colorado. Evolve has already launched its NanoSerum product for the recreational and medical cannabis markets in Colorado. NanoSerum is the clinically tested transdermal cannabis product to relieve pain. The Company is owner of NanoSphere Health Sciences LLC which is, a biotechnology firm specializing in the creation of the NanoSphere Delivery System, a platform using nanotechnology in the biodelivery of supplements, nutraceuticals and over-the-counter medications for the cannabis, pharmaceutical and animal health industries.
Company Coordinates stock-summary
Company Details
8400 E Crescent Pkwy Ste 600 , GREENWOOD VILLAGE CO : 80111-2842
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
0 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 0 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.03

stock-summary
Return on Equity

18.68%

stock-summary
Price to Book

-0.16